Gene: ACTC1

70
ACTC|ASD5|CMD1R|CMH11|LVNC4
actin, alpha, cardiac muscle 1
protein-coding
15q14
Ensembl:ENSG00000159251 MIM:102540 Vega:OTTHUMG00000129675 UniprotKB:P68032
NG_007553.1
PubMed
0   ANCO-SNPs
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
3.297e-1 (AD)  5.635e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
MYBPC30.743
MYH70.696
ANKRD10.693
TECRL0.684
DES0.665
CSRP30.656
TNNI30.639
MYOM30.631
CASP140.613
TNNC10.611

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SLC25A48-0.319
C6orf99-0.283
GAGE10-0.281
HHATL-0.28
RFTN2-0.279
KIAA1755-0.27
GAL3ST1-0.268
TBX6-0.268
APOA4-0.263
HPN-0.262

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0297902,2',3',4,4',5-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACTC1 mRNA"25510870
C0817662,4,4'-trichlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACTC1 mRNA"25510870
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACTC1 mRNA"25510870
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACTC1 mRNA"25510870
C0094072,5,2',5'-tetrachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACTC1 mRNA"25510870
C5185762-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate"2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate results in increased expression of ACTC1 mRNA"17327690
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTC1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTC1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTC1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTC1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTC1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTC1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTC1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTC1 mRNA"27188386
D000082AcetaminophenAcetaminophen affects the expression of ACTC1 mRNA17562736
D000082Acetaminophen[Clofibrate co-treated with Acetaminophen] affects the expression of ACTC1 mRNA17585979
D000082AcetaminophenPPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACTC1 mRNA]17585979
D019342Acetic AcidAcetic Acid results in decreased expression of ACTC1 protein21296659
D000171AcroleinAcrolein affects the metabolism of ACTC1 protein17921335
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of ACTC1 mRNA19770486
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of ACTC1 mRNA22316170
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of ACTC1 mRNA19770486|2222880
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ACTC1 mRNA25566086
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydeMYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ACTC1 mRNA]25566086
D004958EstradiolEstradiol affects the expression of ACTC1 mRNA23184660
C095105bexarotenebexarotene results in increased expression of ACTC1 mRNA16648578
C006780bisphenol Abisphenol A results in decreased expression of ACTC1 mRNA27685785
C006780bisphenol Abisphenol A results in decreased expression of ACTC1 mRNA27178563
C006780bisphenol Abisphenol A results in increased expression of ACTC1 mRNA24134786
C006780bisphenol Abisphenol A results in increased expression of ACTC1 mRNA26794494
C487049BXL628BXL628 results in decreased expression of ACTC1 mRNA16003237
D002220CarbamazepineCarbamazepine affects the expression of ACTC1 mRNA25979313
D002330CarmustineCarmustine results in decreased expression of ACTC1 mRNA15980968
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTC1 mRNA"27188386
D020245p-Chloromercuribenzoic Acidp-Chloromercuribenzoic Acid results in increased expression of ACTC1 mRNA26272509
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACTC1 mRNA20938992
D002994Clofibrate[Clofibrate co-treated with Acetaminophen] affects the expression of ACTC1 mRNA17585979
D002994ClofibratePPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACTC1 mRNA]17585979
D002994ClofibrateClofibrate results in decreased expression of ACTC1 mRNA22300585
D019327Copper SulfateCopper Sulfate results in decreased expression of ACTC1 mRNA19549813
D003471CuprizoneCuprizone affects the expression of ACTC1 mRNA27523638
D003471CuprizoneCuprizone results in decreased expression of ACTC1 mRNA26577399
D003561CytarabineCytarabine results in decreased expression of ACTC1 mRNA21198554
D000069439DasatinibDasatinib results in increased expression of ACTC1 mRNA20579391
C010902decabromobiphenyl etherdecabromobiphenyl ether results in decreased expression of ACTC1 mRNA23640034
C010902decabromobiphenyl etherdecabromobiphenyl ether results in increased expression of ACTC1 mRNA23914054
D003907Dexamethasone[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTC1 mRNA16054899
D003907DexamethasoneTetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTC1 mRNA]16054899
C036042dicyclohexyl phthalatedicyclohexyl phthalate affects the expression of ACTC1 mRNA26924002
C058705diethyl malatediethyl malate affects the expression of ACTC1 mRNA24814887
D004121Dimethyl SulfoxideDimethyl Sulfoxide results in decreased expression of ACTC1 mRNA22105179
D004121Dimethyl SulfoxideDimethyl Sulfoxide results in increased expression of ACTC1 mRNA22105179
D004237DiuronDiuron results in decreased expression of ACTC1 mRNA21551480
D004317DoxorubicinDoxorubicin results in increased expression of ACTC1 protein21251210
D004317Doxorubicinsodium nitrate inhibits the reaction [Doxorubicin results in increased expression of ACTC1 protein]21251210
C070609EMD 53998EMD 53998 analog results in decreased expression of ACTC1 mRNA24977338
C118739entinostatentinostat results in decreased expression of ACTC1 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTC1 mRNA"27188386
D004791Enzyme Inhibitors[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACTC1 protein23301498
D004964EstriolEstriol affects the expression of ACTC1 mRNA23184660
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of ACTC1 mRNA17555576
D005472FluorouracilFluorouracil results in decreased expression of ACTC1 protein21296659
D005492Folic AcidFolic Acid affects the expression of ACTC1 mRNA17320366
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACTC1 mRNA20938992
D005557FormaldehydeFormaldehyde results in decreased expression of ACTC1 mRNA17938736
C039281furanfuran results in increased methylation of ACTC1 gene22079235
D006820Hyaluronic AcidHyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ACTC1 protein]23178681
D006861Hydrogen PeroxideHyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ACTC1 protein]23178681
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of ACTC1 protein23178681
D0150561-Methyl-3-isobutylxanthine[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTC1 mRNA16054899
D0150561-Methyl-3-isobutylxanthineTetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTC1 mRNA]16054899
D058185Magnetite Nanoparticles[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACTC1 mRNA26378955
D008694MethamphetamineMethamphetamine results in decreased expression of ACTC1 mRNA25290377
D008713MethimazoleMethimazole results in increased expression of ACTC1 mRNA17403546
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACTC1 mRNA20938992
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of ACTC1 mRNA23179753
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of ACTC1 mRNA23179753|2627250
C004925methylmercuric chloride"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTC1 mRNA"27188386
D008767Methylmercury CompoundsMethylmercury Compounds results in increased expression of ACTC1 mRNA27544571
C091888monoisoamyl-2,3-dimercaptosuccinate"monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of ACTC1 mRNA]"19615344
C091888monoisoamyl-2,3-dimercaptosuccinate"monoisoamyl-2,3-dimercaptosuccinate results in decreased expression of ACTC1 mRNA"19615344
D037742Nanotubes, Carbon"Nanotubes, Carbon affects the expression of ACTC1 mRNA"23845593
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of ACTC1 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of ACTC1 mRNA"25554681
C017557nickel subsulfidenickel subsulfide affects the expression of ACTC1 mRNA24952340
C017557nickel subsulfidenickel subsulfide results in increased expression of ACTC1 mRNA21086188
C029938nickel sulfatenickel sulfate results in decreased expression of ACTC1 mRNA16100012
C572573N-nitroso-tris-chloroethylurea[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ACTC1 mRNA27935865
D010126OzoneOzone results in decreased expression of ACTC1 mRNA12763052
C410127PCB 180"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACTC1 mRNA"25510870
C494474perchlorateperchlorate results in increased expression of ACTC1 mRNA17403546
D010634PhenobarbitalPhenobarbital results in increased expression of ACTC1 mRNA19162173
C060836pioglitazone[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ACTC1 mRNA27935865
C006253pirinixic acidpirinixic acid results in increased expression of ACTC1 mRNA17951219
D028321Plant PreparationsPlant Preparations results in decreased expression of ACTC1 mRNA26945725
D011374ProgesteroneProgesterone results in decreased expression of ACTC1 mRNA23012394
D011374ProgesteroneProgesterone results in decreased expression of ACTC1 mRNA21795739
C045950propiconazolepropiconazole results in increased expression of ACTC1 mRNA21278054
D011441PropylthiouracilPropylthiouracil results in increased expression of ACTC1 mRNA24780913
D011441PropylthiouracilPropylthiouracil results in increased expression of ACTC1 mRNA17403546
D011794QuercetinQuercetin results in increased expression of ACTC1 protein18095365
C089730rosiglitazone[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTC1 mRNA16054899
C089730rosiglitazoneTetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTC1 mRNA]16054899
C009277sodium arsenatesodium arsenate results in increased expression of ACTC1 mRNA21795629
C017947sodium arsenite"monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of ACTC1 mRNA]"19615344
C017947sodium arsenitesodium arsenite results in decreased expression of ACTC1 mRNA19615344
D012969Sodium FluorideSodium Fluoride results in decreased expression of ACTC1 protein27548804|2891852
C031618sodium nitratesodium nitrate inhibits the reaction [Doxorubicin results in increased expression of ACTC1 protein]21251210
D013311StreptozocinStreptozocin results in decreased expression of ACTC1 protein21136691
D004113Succimer[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACTC1 mRNA26378955
D013629TamoxifenTamoxifen affects the expression of ACTC1 mRNA17555576
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of ACTC1 mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTC1 mRNA]16054899
C009495titanium dioxidetitanium dioxide results in decreased expression of ACTC1 mRNA23557971
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of ACTC1 mRNA19969065
D014241TrichloroethyleneTrichloroethylene results in decreased expression of ACTC1 mRNA19448997
C012589trichostatin Atrichostatin A results in decreased expression of ACTC1 mRNA24935251
D014266TrientineTrientine results in decreased expression of ACTC1 protein21136691
D014520UrethaneUrethane results in increased expression of ACTC1 mRNA28818685
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTC1 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of ACTC1 mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of ACTC1 mRNA23179753|2438349
D014635Valproic AcidValproic Acid results in increased expression of ACTC1 mRNA23179753
D014635Valproic AcidValproic Acid results in increased expression of ACTC1 mRNA24896083
D014638VanadatesVanadates results in decreased expression of ACTC1 mRNA22714537
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of ACTC1 gene25560391
D015032ZincZinc results in decreased expression of ACTC1 mRNA17074742
D019287Zinc SulfateZinc Sulfate results in decreased expression of ACTC1 mRNA17074742

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005524ATP binding-IDA16611632  
GO:0016887ATPase activity-IDA16611632  17765196  
GO:0017022myosin binding-IDA19799913  
GO:0017022myosin binding-IPI16611632  
GO ID GO Term Qualifier Evidence PubMed
GO:0010628positive regulation of gene expression-ISS-  
GO:0030048actin filament-based movement-IDA16611632  
GO:0030049muscle filament sliding-TAS-  
GO:0030240skeletal muscle thin filament assembly-ISS-  
GO:0031032actomyosin structure organization-ISS-  
GO:0033275actin-myosin filament sliding-IMP19799913  
GO:0043066negative regulation of apoptotic process-IEA-  
GO:0045471response to ethanol-IEA-  
GO:0055003cardiac myofibril assembly-ISS-  
GO:0055008cardiac muscle tissue morphogenesis-ISS-  
GO:0060047heart contraction-IMP9563954  17611253  17947298  
GO:0060048cardiac muscle contraction-IEA-  
GO:0090131mesenchyme migration-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005615extracellular space-HDA22664934  23580065  
GO:0005737cytoplasm-IDA20962418  
GO:0005829cytosol-TAS-  
GO:0005884actin filament-IDA16611632  19799913  
GO:0005925focal adhesion-HDA21423176  
GO:0016020membrane-HDA19946888  
GO:0030017sarcomere-IDA16288873  
GO:0030027lamellipodium-ISS-  
GO:0030175filopodium-ISS-  
GO:0031674I band-ISS-  
GO:0042643actomyosin, actin portion-IDA16611632  
GO:0044297cell body-ISS-  
GO:0070062extracellular exosome-HDA21362503  23533145  
GO:0072562blood microparticle-HDA22516433  
KEGG ID KEGG Term
hsa04260Cardiac muscle contraction
hsa05410Hypertrophic cardiomyopathy (HCM)
hsa05414Dilated cardiomyopathy
Reactome ID Reactome Term Evidence
R-HSA-390522Striated Muscle ContractionTAS
R-HSA-397014Muscle contractionTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
20441232Discovering disease-specific biomarker genes for cancer diagnosis and prognosis. (2010 Jun)Huang HCTechnol Cancer Res Treat